Ibrain Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.25 Cr
- Paid Up Capital ₹ 2.47 Cr
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 20.21%
- Profit Growth 774.09%
- Ebitda 11.89%
- Net Worth 4.46%
- Total Assets 6.03%
About Ibrain Healthcare
Ibrain Healthcare Private Limited (IHPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 March 2013 and has a history of 11 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.25 Cr and a paid-up capital of Rs 2.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamalendra Pamulapati, Phani Mulakaluri, Vijay Seshadri, and Three other members serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74140TG2013PTC086008
-
Company No.
086008
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Mar 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ibrain Healthcare?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devulapally Rao
|
Director | 27-Jun-2013 | Current |
|
Kamalendra Pamulapati
|
Director | 01-Mar-2013 | Current |
|
Phani Mulakaluri
|
Director | 01-Mar-2013 | Current |
|
Vijay Seshadri
|
Director | 27-Jun-2013 | Current |
|
Philipkumar Boyanapally
|
Director | 19-Apr-2023 | Current |
| Nishanth Vemana | Director | 19-Apr-2023 | Current |
Financial Performance of Ibrain Healthcare.
Ibrain Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.21% increase. The company also saw a substantial improvement in profitability, with a 774.09% increase in profit. The company's net worth moved up by a moderate rise of 4.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ibrain Healthcare?
In 2020, Ibrain Healthcare had a promoter holding of 20.66% and a public holding of 79.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibrain Healthcare?
Ibrain Healthcare has a workforce of 17 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibrain Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibrain Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
